Board Meeting14 Oct 2026, 04:12 pm
Bacil Pharma Board Approves Unaudited Financial Results for H1 FY27
AI Summary
Bacil Pharma Limited's Board of Directors met on October 14, 2026, and approved the unaudited financial results for the half-year and quarter ended September 30, 2026. The results, along with the Limited Review Report from the statutory auditors, will be submitted separately. The meeting commenced at 3:00 PM and concluded at 4:00 PM.
Key Highlights
- Board meeting held on October 14, 2026.
- Approved unaudited financial results for H1 FY27.
- Limited Review Report from auditors also approved.
- Results to be submitted in prescribed format.
Price Impact
More from BACPHAR